Key points from article :
UNITY develops therapeutics to slow, halt or reverse diseases of aging.
Treated first patient in Phase 1 clinical trial evaluating UBX0101.
Patient suffers from moderate to severe osteoarthritis of the knee.
Osteoarthritis is one of the main reasons why it hurts to get old.
Treatment selectively eliminates senescent cells in the joints.
Phase 1 clinical trial of single ascending dose evaluates safety.
